Home

Bangladesh Academy of Pathology


Bangladesh Academy of Pathology(BAP) aims to work with national and international organizations like International Academy of Pathology(IAP)to achieve excellence in education, training, research and quality service in Pathology in Bangladesh.

The Bangladesh Academy of Pathology was officially launched and its first general meeting was held in the Department of Pathology, Bangladesh Medical University, on Friday, the 7th of December 2012. A total of 58 specialist pathologists from all over the country were present at the meeting. Twenty Councillors were elected, amongst whom, the President, President elect, Vice President, Treasurer and General Secretary were selected for the next two years. The elected Councillors were: Dr. A J E Nahar Rahman (President), Dr. Mohammed Kamal (President elect), Dr. Kaniz Rasul (Vice President), Dr. Ashim Ranjan Barua (Treasurer), and Dr. Maleeha Hussain (General Secretary), Dr. Md Sadequel Islam Talukder, Dr. S M Badruddoza, Dr. Sukumar Saha, Dr. Abed Hossain, Dr. M Shahabuddin Ahmed, Dr. AFM Saleh, Dr. PK Gosh, Dr. Shabnam Akhter, Dr. Shamiul Islam Sadi, Dr. Kamrul Hassan Khan, Dr. Farooque Ahmed, Dr Abdul Mannan Sikder, Dr. Col. Mahbubul Alam, Dr. Taslima Hossain and Dr. AUM Muhsin.



 

jhc.2026.10.1.10

Journal of Histopathology and Cytopathology
Vol 10. Issue 1, 2026

Uniform Criteria for Submission of Manuscript to the Editorial Board
[According to Guideline of BMDC]

  1. Manuscript written in English on bio medical topics will be considered for publication provided these have not been published previously and are not under consideration for publication elsewhere.
  2. The author should obtain written permission from appropriate authority if the manuscript contains any table, data or illustration from previously published in other Journal. The letter of permission should be submitted with manuscript to the editorial board.
  3. Authors should keep one copy of their manuscript for reference & three hard copies along with softcopy should be sent to the managing editor.
  4. The authors should sign a covering letter mentioning that final manuscript has been seen and approved by all authors. Relevancy and contribution of coauthors should clearly mentioned by first author. Irrelevant person or without any contribution should not be entitled as coauthors.
  5. The materials submitted for publication may be in the form of an original research, review article, special article, a case report, recent advances, new techniques, books review on clinical / medical education, adverse drug reaction or a letter to the editor.
  6. An author can write review article only if he / she has written a minimum of two (2) original research articles and four (4) case reports on the same topic.
  7. The manuscript may be submitted by the author online following appropriate criteria as mentioned.
  8. Each component of the manuscript should begin on a new page in the sequence of-
    1. Title page
    2. Abstract
    3. Text- Introduction, Material & Methods, Result and Discussion.
    4. References
    5. Acknowledgement
  9. The title page should include the title of the paper, name of the authors, name of the departments in which they worked, email address & phone number.
  10. The title should be concise, informative & self explanatory.
  11. The Abstract should be structured as-introduction with objectives, materials & methods, result, discussion with conclusion including key words number of figures, tables, reference & correspondence
  12. The text should be presented in the form of-
    1. Introduction: This should include the purpose of the article. The rational for the study or observation should be summaries. Only strictly pertinent reference should be cited. The subject should not be extensively reviewed. Data or conclusion from the work being reported should not be presented in introduction.
    2. Materials & methods: study design & sampling method should be mentioned. Consent from respondents / patients should be taken in the form before interview / study. All drugs & chemicals used should be identified precisely, including generic name, dose route of administration. For all quantitative measurement SI unit should be used.
    3. Results: This should be presented in a logical sequence in the text, tables & illustration. For Statistical Analysis standard procedure to be maintained. It should be done by a recognized statistician or subject expert related to statistics.
    4. Discussion: Authors comment on the result supported with contemporary references including arguments and analysis of identical work done by other workers may be elaborately discussed. A summary is not required. Brief acknowledgement may be made at the end.
    5. Tables: Number and titles of tables to be clearly written.
    6. Source of Illustrations & Figures should be mentioned.
    7. Abbreviations and Symbols: Use only standard abbreviations; avoid abbreviations in the title of the article.
  13. References-
    1. Reference should be numbered in order to which they appear in the text as superscript.
    2. Reference should be in Vancouver style

============================================
*Authors are requested to send manuscript of article via email attached MS Word file.

Email: sadequel@yahoo.com
Open as PDF

jhc.2026.10.1.9

Journal of Histopathology and Cytopathology
Vol 10, Issue 1, 2026

Comparative Analysis of Serum β-hCG Levels in Complete and Partial Hydatidiform Moles
 Rahman MM,1 Kabir AN,2 Islam T,3 Shiraj-Um-Mahmuda S,4 Karim R,5 *Shabnam US6

Abstract
Introduction: Hydatidiform mole (HM) is a gestational trophoblastic disorder caused by abnormal fertilization, resulting in a non-viable pregnancy with trophoblastic hyperplasia. Differentiation between complete hydatidiform mole (CHM) and partial hydatidiform mole (PHM) is clinically important because CHM carries a higher risk of persistent trophoblastic disease. Serum β-hCG is often markedly elevated in molar pregnancy and may assist in distinguishing CHM from PHM. This study aimed to evaluate pretreatment β-hCG levels among different types of hydatidiform mole and assess their diagnostic association.
Methods: This cross-sectional study included 57 histopathologically diagnosed cases of HM collected from the BMU and private laboratories in Dhaka. Pretreatment serum β-hCG levels were obtained for all patients. Based on histopathological criteria, cases were grouped into CHM, PHM, and indeterminate categories. Statistical analysis using Mann-Whitney and Kruskal-Wallis tests was performed to compare β-hCG levels between groups.
Results: Of the 57 cases, 36 were CHM, 13 were PHM, and 8 were categorized as indeterminate. Serum β-hCG levels showed statistically significant variation among the three groups, with CHM showing markedly higher levels than PHM. Elevated β-hCG demonstrated a strong association with the histopathological diagnosis of HM.
Conclusion: Pretreatment serum β-hCG level is a valuable adjunct in differentiating complete from partial hydatidiform mole. When used alongside histopathological assessment, β-hCG can enhance diagnostic confidence and guide appropriate clinical management.

[Journal of Histopathology and Cytopathology, 2026 Jan; 10 (1):71-83]
DOI: https://www.doi.org/10.69950/jhc.2026.10.1.9

Keywords: β-hCG, complete hydatidiform mole, partial hydatidiform mole, trophoblastic disease.

  1. Dr. Mohammad Mosiur Rahman, Associate Professor, Patholog), Bangladesh Medical University, Bangladesh. mosiurpath@bsmmu.edu.bd.
  2. Dr. AKM Nurul Kabir, Professor, Pathology, Bangladesh Medical University, Dhaka
  3. Dr. Tasmia Islam, Assistant Professor, Pathology, Bangladesh Medical University. Dhaka
  4. Dr. Syeeda Shiraj-Um-Mahmuda, MD (Pathology), OSD, Directorate General of Health Services (DGHS).
  5. Dr. Rezwana Karim, Associate Professor (C.C), Pathology, US – Bangla Medical College and Hospital, Dhaka
  6. *Dr. Ummey Salma Shabnam, Assistant Professor (Histopathology), National Institute of Cancer Research and Hospital, Place. salmamithun@gmail.com. Orcid id: 0009-0005-1751-116X,

*For correspondence

Open full Article as PDF

jhc.2026.10.1

Journal of Histopathology and Cytopathology
Official Journal of Bangladesh Academy of Pathology
Vol 10, No 1, January 2026

Editorial

1. Pathologic Evaluation of Breast Carcinoma after Neoadjuvant Therapy: The Need for Standardized Reporting
Anjum R

Original Contributions

  1. Expression of Cyclin D1 in Gastric Adenocarcinoma and its Association with Staging
    Lubna NT, Jeba R, Rana MS, Khan RR, Islam MM, Kabir E, Badhan RE
  1. Histomorphological Alterations of the Human Heart: An Autopsy-Based Analysis at Dhaka Medical College
    Aktar M, Jeba R, Khatun J, Lubna NT, Nahar R, Ara J, Badhan RE
  1. Expression of FLI1 in Astrocytoma and its Association with WHO Grade
    Sultana S, Rahiduzzaman SM, Yeamin MA, Rashid HO, Akter J, Islam M, Jeba R
  1. Expression of FLI1 in Astrocytoma and its Association with Histological Parameters
    Sultana S, Khan ZB, Rahiduzzaman SM, Doly NJ, Tahsin KN, Jannat MR, Ahmed S, Kashfi SK
  1. Genetic Profile of Spinal Muscular Atrophy: A Case Series from Bangladesh
    Nahid MS, Hoque MM
  1. Expression of p53 in Urothelial Carcinoma of the Urinary Bladder: Correlation with Tumor Grade and Muscle Invasion
    Azim T, Jinnah MS, Aktar M, Ahmed M, Badhan RE
  1. Histopathologic Findings of Breast Lesions and It’s Association with Corresponding Radiologic Findings.
    Datta T, Asaduzzaman, Ray TK, Hoque MM
  1. Comparative Analysis of Serum β-hCG Levels in Complete and Partial Hydatidiform Moles
    Rahman MM, Kabir AN, Islam T, Shiraj-Um-Mahmuda S, Karim R, Shabnam US

Information for Contributors

Index as PDF

 

Journal of Histopathology and Cytopathology
Official Journal of Bangladesh Academy of Pathology
Vol 10, No 1, January 2026

Editorial Board
Editor in Chief : Dr. Sadequel Islam Talukder
Executive Editor : Dr. Asaduzzaman
Associate Editor : Professor M Shahab Uddin Ahamad
: Brig Gen (rtd) Professor Sk Md Jaynul Islam
: Professor Dr. Sultana Gulshana Banu
: Professor Dr. Enamul Kabir
: Dr. Shabnam Akhter
: Professor Dr. Saequa Habib
: Professor (CC) Dr. Md. Mahmudul Huda (Himel)
: Dr. Farida Arjuman
Assistant Editor : Dr. Mohammad Mahabubul Haque
: Dr. Md. Shahrior Nahid
: Dr. Md. Shahadat Hossain Jewel
Members : Professor Ferdousy Begum
: Professor Ruksana Jeba
: Professor Shahnaj Begum
: Professor Shamima Ferdousi
: Professor Shamim Farooq (Titu)
: Dr. Taslima Hossain
: Dr. Shahnaz Pervin
: Dr. Mohammad Mosiur Rahman
: Dr. Naznin Nahar Aymon

Journal of Histopathology and Cytopathology
Official Organ of Bangladesh Academy of Pathology
Vol 10, No 1, January 2026

Advisory Board
Professor AJE Nahar Rahman
Professor Abdul Mannan Sikder
Professor Fouzia Akhtar Banu
Professor Badrul Islam
Professor Shah Monir Hossain
Professor Tareak Al Nasir
Professor Md. Fazlur Rahman
Professor Kaniz Rasul
Professor Ashim Ranjan Barua
Professor AUM Muhsin
Professor Farooque Ahmad
Professor Md. Golam Mostofa
Professor Md. Nasimul Islam
Professor Paritosh Kumar Ghosh
Professor Md. Zillur Rahman
Professor Md. Rezaul Karim Dewan